International Stem Cell Corp (OTCMKTS:ISCO) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.68 and traded as high as $0.73. International Stem Cell shares last traded at $0.73, with a volume of 715 shares trading hands.
Separately, Zacks Investment Research cut shares of International Stem Cell from a “buy” rating to a “hold” rating in a report on Tuesday, May 26th.
The stock’s 50-day moving average is $0.75 and its 200-day moving average is $0.68.
International Stem Cell (OTCMKTS:ISCO) last announced its earnings results on Friday, June 19th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter. The company had revenue of $2.36 million for the quarter.
International Stem Cell Company Profile (OTCMKTS:ISCO)
International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes.
Featured Story: Overbought
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.